Filing Details
- Accession Number:
- 0000899243-16-021724
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-03 18:04:44
- Reporting Period:
- 2016-06-01
- Filing Date:
- 2016-06-03
- Accepted Time:
- 2016-06-03 18:04:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1596946 | Quotient Ltd | QTNT | In Vitro & In Vivo Diagnostic Substances (2835) | 264719797 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1604630 | Stephen Unger | Elizabeth House, 9 Castle Street St Helier Y9 JE2 3RT | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2016-06-01 | 1,503 | $10.78 | 21,497 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2016-06-02 | 7,013 | $10.43 | 14,484 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Employee Stock Option (right to buy) | Acquisiton | 2016-06-01 | 15,000 | $0.00 | 15,000 | $11.92 |
| Ordinary Shares | Multi-year Performance Based Restricted Stock Units | Acquisiton | 2016-06-01 | 15,000 | $0.00 | 15,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,000 | 2026-05-31 | No | 4 | A | Direct | |
| 15,000 | 2018-12-31 | No | 4 | A | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Multi-year Performance Based Restricted Stock Units | $0.00 | 2018-12-31 | 22,500 | 22,500 | Direct | |
| Ordinary Shares | Employee Stock Option (right to buy) | $15.17 | 2025-05-19 | 22,500 | 22,500 | Direct | |
| Ordinary Shares | Employee Stock Option (right to buy) | $8.00 | 2024-04-29 | 50,800 | 50,800 | Direct | |
| Ordinary Shares | Options to Purchase Ordinary shares | $8.00 | 2024-03-03 | 67,200 | 67,200 | Direct | |
| Ordinary Shares | Options to Purchase Ordinary shares | $3.29 | 2023-06-27 | 32,000 | 32,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2018-12-31 | 22,500 | 22,500 | Direct |
| 2025-05-19 | 22,500 | 22,500 | Direct |
| 2024-04-29 | 50,800 | 50,800 | Direct |
| 2024-03-03 | 67,200 | 67,200 | Direct |
| 2023-06-27 | 32,000 | 32,000 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.75 to $10.895, inclusive. The Reporting Person undertakes to provide Quotient, any security holder of Quotient, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.25 to $10.79, inclusive. The Reporting Person undertakes to provide Quotient, any security holder of Quotient, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- The options will vest and become exercisable in three equal annual installments beginning on June 1, 2017.
- Each Multi-year Performance Based Restricted Stock Unit ("MRSU") represents a contingent right to receive one share of Quotient's ordinary shares. The MRSUs vest upon Quotient's ordinary shares achieving a volume weighted average market price of $40.00 per share for 20 consecutive trading days during the period April 1, 2018 to December 31, 2018.
- Each MRSU represents a contingent right to receive one share of Quotient's ordinary shares. The MRSUs vest upon Quotient's ordinary shares achieving a volume weighted average market price of $60.00 per share for 20 consecutive trading days during the period April 1, 2018 to December 31, 2018.
- 7,500 options vested on 5/20/2016 and remain exercisable, 7,500 will vest on 5/20/2017, 7,500 will vest on 5/20/2018.
- 33,866 options have vested and remain exercisable, 16,934 options will vest on 4/29/2017.
- 44,800 options have vested and remain exercisable, 22,400 options will vest on 3/4/2017.
- 21,334 options have vested and remain exercisable, 10,666 options will vest on 6/28/2016.
Billionaire Hedge Funds
